Invesco India Pharma and Healthcare Fund - Direct (G): NFO Details
Scheme Objective
To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
Risk-o-meter
moderate Moderate Moderately
High High Very
High
Fund House Details
More Funds from Invesco Mutual Fund
| Fund Name | Rating | 3 Year CAGR | 5 Year CAGR |
|---|---|---|---|
| Invesco India Gold ETF Fund of Fund - Direct Growth |
3★ | 35.46% | 25.23% |
| Invesco India - Invesco EQQQ NASDAQ-100 ETF Fund of Fund - Dir Growth |
★ | 29.85% | - |
| Invesco India Mid Cap Fund - Direct Growth |
4★ | 23.38% | 20.20% |
| Invesco India - Invesco GEI Fund of Fund - Direct Growth |
0★ | 23.15% | 17.57% |
| Invesco India Large & Mid Cap Fund-Dir Growth |
4★ | 22.73% | 17.56% |
Fund House Contact Details
Other Calculators
Frequently Asked Questions
To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
Open date of Invesco India Pharma and Healthcare Fund - Direct (G) 18 Aug 2026
Close date of Invesco India Pharma and Healthcare Fund - Direct (G) 01 Sep 2026
The minimum investment amount of Invesco India Pharma and Healthcare Fund - Direct (G) ₹1000
The Fund Manager of Invesco India Pharma and Healthcare Fund - Direct (G) is Taher Badshah